C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
11/2004
11/11/2004	US20040224336 RecA-assisted specific oligonucleotide extension method for detecting mutations, SNPs and specific sequences
11/11/2004	US20040224335 Methods and compositions for treatment of tumors using nucleic acid ligands to platelet-derived growth factor
11/11/2004	US20040224330 Nucleic acid indexing
11/11/2004	US20040224309 Nucleotide sequences coding viral genome for use in developing vaccine to prevent respiratory system infections; genetic vaccines
11/11/2004	US20040223968 inhibiting a condition characterized by monocytic infiltrates such as atherosclerosis by administering an MCP-1 receptor antagonist that binds to an MCP-1 receptor polypeptide, especially a humanized or monoclonal antibody.
11/11/2004	US20040223964 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/11/2004	US20040223323 Optical information carrier comprising immobilized proteorhodopsin
11/11/2004	CA2524585A1 Nucleoside derivative, modified oligonucleotide, method for their synthesis and applications thereof
11/11/2004	CA2523501A1 Preservation of rna in a biological sample
11/11/2004	CA2523442A1 Molecular detection systems utilizing reiterative oligonucleotide synthesis
11/11/2004	CA2523266A1 Compositions comprising cationic microparticles and hcv e1e2 dna and methods of use thereof
11/11/2004	CA2523025A1 Spex compositions and methods of use
11/11/2004	CA2522890A1 Method for selective inhibition of human n-myc gene in n-myc expressing tumors through anti-sense and sense peptide nucleic acids
11/11/2004	CA2522154A1 Recombinant plant dicer
11/11/2004	CA2519241A1 Compositions and methods for the diagnosis and treatment of tumor
11/10/2004	EP1475445A1 Method of detecting micrometastasis
11/10/2004	EP1475440A2 Growth differentiation factor-3
11/10/2004	EP1474530A2 Probe correction for gene expression level detection
11/10/2004	EP1474515A2 Regulation of human hematopoietin receptor-like protein
11/10/2004	EP1474513A1 Signalling aptamer complexes
11/10/2004	EP1474505A1 Vaccination and vaccine and drug delivery by topical application of vectors and vector extracts recombinant vectors, and noninvasive genetic immunization, expression products therefrom,and uses thereof
11/10/2004	EP1474444A1 A novel splice variant of myd88 and uses thereof
11/10/2004	EP1474434A2 The eaat2 promoter and uses thereof
11/10/2004	EP1474432A1 Immunostimulatory, covalently lipidated oligonucleotides
11/10/2004	EP1474430A1 Bi-functionalised metallocenes use for marking biological molecules
11/10/2004	EP1261617A4 Methods for assay and detection on a microarray
11/10/2004	EP1112377A4 Nucleic acid-coupled colorimetric analyte detectors
11/10/2004	EP1005573A4 Dendritic nucleic acids exhibiting maximal self-assembly
11/10/2004	EP0658206B1 Inhibitor resistant serine proteases
11/10/2004	CN1544653A Gene synapsin II associated with schizophrenia and polymorphism site and use thereof
11/10/2004	CN1544627A Phase separation method for biomacromolecule components
11/10/2004	CN1544467A Variable region gene of high neutralization activity monoclonal antibody of tumor necrosis factor and its preparation
11/10/2004	CN1544466A Variable region gene of high affinity monoclonal antibody of tumor necrosis factor and its preparation
11/10/2004	CN1544454A Antisense nucleic acid for multiple drug resistance gene of human epidermis tumor cell
11/10/2004	CN1175106C Human insulin recombinant gene, preparation method and application
11/09/2004	US6815429 Modulation of oligonucleotide CpG-mediated immune stimulation by positional modification of nucleosides
11/09/2004	US6815190 Having improved thermostability; used in the enzymatic hydrolysis of cyclic oligomers of poly(ethylene terephthalate) in the finishing of yarn or fabric from fibers
11/09/2004	US6815164 Methods and probes for detection and/or quantification of nucleic acid sequences
11/09/2004	US6815161 Detection of Mycoplasma in patients with chronic fatigue syndrome and related disorders
11/09/2004	US6814967 Polypeptides
11/09/2004	CA2138137C Diphtheria toxin vaccines
11/04/2004	WO2004095025A1 Improved composite microarry slides
11/04/2004	WO2004094641A2 A novel method of modulating bone-realted activity
11/04/2004	WO2004094615A2 Prokaryotic collagen-like proteins and uses thereof
11/04/2004	WO2004094613A2 Polyvalent protein complex
11/04/2004	WO2004094606A2 COMPOSITIONS AND METHODS FOR siRNA INHIBITION OF ANGIOPOIETIN 1 AND 2 AND THEIR RECEPTOR TIE2
11/04/2004	WO2004094597A2 Anthozoan fluorescent protein genes
11/04/2004	WO2004094595A2 MODIFIED iRNA AGENTS
11/04/2004	WO2004094593A2 Expanding the eukaryotic genetic code
11/04/2004	WO2004094590A2 Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins
11/04/2004	WO2004094463A2 Peptide inhibitors of autophosphorylation protein kinases
11/04/2004	WO2004094455A2 Prophylactic and therapeutic benefits of new class of immune stimulating peptides
11/04/2004	WO2004094448A1 METHYLATED CpG POLYNUCLEOTIDE
11/04/2004	WO2004094447A1 Thionucleoside s-nitrosyl derivative
11/04/2004	WO2004094345A2 Protected monomers
11/04/2004	WO2004094027A2 Microfiltration and/or ultrafiltration process for recovery of target molecules from polydisperse liquids
11/04/2004	WO2004093820A2 Methods and compositions for solid tumor treatment
11/04/2004	WO2004093810A2 Methods and compositions for treating disorders
11/04/2004	WO2004093797A2 Methods, devices, and compositions for lysis of occlusive blood clots while sparing wound sealing clots
11/04/2004	WO2004093790A2 Yeast ectopically expressing abnormally processed proteins and uses therefor
11/04/2004	WO2004093788A2 Desmoglein 4 is a novel gene involved in hair growth
11/04/2004	WO2004093785A2 Rhesus monkey bombesin receptor subtype-3 (brs-3), nucleotides encoding same, and uses thereof
11/04/2004	WO2004093645A2 Tn5 transposase mutants and the use thereof
11/04/2004	WO2004085989A3 Dye compositions which provide enhanced differential fluorescence and light scatter characteristics
11/04/2004	WO2004061077A3 Increasing gamete production with a gene switch
11/04/2004	WO2004053143A3 Concurrent enzymatic polynucleotide synthesis and detectable signal generation
11/04/2004	WO2004047514A3 Methods for identifying risk of breast cancer and treatments thereof
11/04/2004	WO2004027043A3 Method for production of a multimeric protein by cell fusion
11/04/2004	WO2004025251A3 Cell-based detection and differentiation of disease states
11/04/2004	WO2004005461A3 Antisense modulation of insulin-like growth factor 2 expression
11/04/2004	WO2003102135A3 Control sequences of the human corin gene
11/04/2004	WO2003087115A3 Oligomeric compounds having modified phosphate groups
11/04/2004	US20040221338 Ribosomal RNA regulatory sequences for use as tools in controlling heterologous gene expression; chloroplast transcription modulating element; tissue engineering
11/04/2004	US20040220397 Solid support for the synthesis of 3'-amino oligonucleotides
11/04/2004	US20040220395 Enhanced triple-helix and double-helix formation with oligomers containing modified pyrimidines
11/04/2004	US20040220385 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/04/2004	US20040220133 Composition and method for inhibiting platelet aggregation
11/04/2004	US20040220130 Compact synthetic expression vector comprising double-stranded DNA molecules and methods of use thereof
11/04/2004	US20040220125 Biosynthetic platform for cardioprotective gene expression using immature heart tissue
11/04/2004	US20040219644 Immunoglobulin for binding monocyte chemoattractant protein-1(MCP-1) and preventing and/or treating atherosclerosis and cancer ; antitumor agents
11/04/2004	US20040219641 Comprises nucleotide sequences coding lipopolysaccharide induced tumor necrosis factor - alpha factor (LITAF) proteins for use in treatment and prevention of cell proliferative disorders; antitumor agents; immunotherapy
11/04/2004	US20040219582 Diagnosing cell proliferative disorders via presence of restriction fragment length polymorphism in fibroblast growth factor (FGF-3) gene
11/04/2004	US20040219579 Identifying nucleic acid and protein expression profiles associated with cell proliferative and metabolic disorders; cancer associated proteins/transcripts and high throughput screening
11/04/2004	US20040219577 Process for the synthesis of oligomeric compounds
11/04/2004	US20040219576 Reactive functional groups
11/04/2004	US20040219571 Genetically engineered RNA self replicating enzyme for use in removal of repetitve triplet codon associated with muscular dystrophy; gene therapeutics and RNA targeting
11/04/2004	US20040219565 Oligonucleotides useful for detecting and analyzing nucleic acids of interest
11/04/2004	US20040219556 Methods and compositions for detection and analysis of polynucleotides using light harvesting multichromophores
11/04/2004	US20040219544 Amplification and detection of mycoplasma pneumoniae
11/04/2004	US20040219539 Treatment of methylated nucleic acid
11/04/2004	US20040219534 Rapid extraction of RNA from cells and tissues
11/04/2004	US20040219529 synthetic bovine Deoxyribonulease I as well as variants that are enzymatically active in hydrolyzing DNA with a catalytic profile that is distinct from that of wild type DNase I cleaving nonspecifically to release 5'-phosphorylated nucleotides
11/04/2004	US20040219523 Ligase ribozyme reporter molecule for diagnostic tool in genomic analysis
11/04/2004	US20040219521 Nucleotide sequences for use as tools in disease diagnostics, forensics, gene mapping, mutation identification and to assess biodiversity
11/04/2004	US20040219520 Oligonucleotide matrix which uses changes in conductivity to detect hybridized nucleotide sequences; sequences determination
11/04/2004	US20040219518 Hepatitis F nucleotide sequences for use as tools in prevention of viral infection and cell proliferative disease; antisense agents; antiproliferative agents
11/04/2004	US20040219517 Methods for rapid identification of pathogens in humans and animals
11/04/2004	US20040219515 Human immunodeficiency viral nucleotide sequences for use as gene therapeutic tools in prevention of viral infection; gene expression inhibition
11/04/2004	US20040219131 Interferon-alpha polypeptides and conjugates
11/04/2004	DE10315772A1 Chemische Verbindung und Verfahren für den intramolekularen Energietransfer zur Abspaltung von labilen funktionellen Gruppen aus chemischen Verbindungen Chemical compound and method for the intramolecular energy transfer to the cleavage of labile functional groups from chemical compounds

1 ... 597 598 599 600 601 602 603 604 605 606 607 608 609 610 611 612 613 614 615 616 617 ... 899